UT-MD Anderson Cancer Center: Shorter Course Of Radiation Therapy Yields Comparable Results For Patients With Non-Metastatic Soft Tissue Sarcoma
November 05, 2022
November 05, 2022
HOUSTON, Texas, Nov. 5 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Nov. 4, 2022:
* * *
Hypofractionated treatment achieves similar tumor control with no increased risk of wound complications
* * *
Patients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely receive hypofractionated treatment over three weeks instead of five, with comparab . . .
* * *
Hypofractionated treatment achieves similar tumor control with no increased risk of wound complications
* * *
Patients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely receive hypofractionated treatment over three weeks instead of five, with comparab . . .